本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mineralys Therapeutics, Inc.

21.00
-1.2300-5.53%
盘后:21.000.00000.00%16:10 EDT
成交量:330.38万
成交额:6,988.78万
市值:18.51亿
市盈率:-4.80
高:22.82
开:22.04
低:20.41
收:22.23
52周最高:47.65
52周最低:20.41
股本:8,815.85万
流通股本:6,602.58万
量比:2.60
换手率:5.00%
股息:- -
股息率:- -
每股收益(TTM):-4.3763
每股收益(LYR):-2.2900
净资产收益率:-80.88%
总资产收益率:-46.18%
市净率:3.36
市盈率(LYR):-9.17

数据加载中...

2025/02/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/12

重要事件披露

Form 8-K - Current report
2025/02/04

重要事件披露

Form 8-K - Current report
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/25

重要事件披露

Form 8-K - Current report
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report